← Leaderboards
Steve Khan
La Biomed Res Inst/ Harbor Ucla Med Ctr
$477,920
Attributed
$477,920
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$477,920 · 2
By mechanism
M01$477,920 · 2
Top collaborators
No co-investigators on record.
Most similar at La Biomed Res Inst/ Harbor Ucla Med Ctr
Same institution · by research overlap
- C. Noel Bairey Merz$16,199,798
- Matthew J Budoff$8,193,036
- Ruey-Kang R Chang$4,293,591
- Rajnish Mehrotra$10,175,876
- Michael Glenn Ross$10,022,584
Others in their field
Top investigators on “Human Therapy Evaluation”
- Lawrence Corey · Fred Hutchinson Cancer Center$368,153,539
- David Heimbrook · Leidos Biomedical Research, Inc.$241,598,366
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$212,820,795
- Barbara Driver · Westat, Inc.$206,347,735
- Carol Nesel · Westat$188,148,170
- Constance Ann Benson · University Of California, San Diego$179,950,251
Research focus
Human Therapy EvaluationHuman SubjectClinical ResearchCardiovascular Disorder ChemotherapyRenin Angiotensin SystemAngiotensin IiCongestive Heart FailureInhibitor /AntagonistWomen'S HealthCoronary ArteryDisease /Disorder Proneness /RiskEstrogensFemaleHeart DisorderHormone TherapyProgesterone
Grant awards (6)
MULTI COUNTRY RANDOMIZED, DOUBLE BLIND TRIAL ON EFFECT OF VALSARTAN IN CHF$237,978
M01 · FY2001 · RR
HEART &ESTROGEN REPLACEMENT STUDY (HERS)$237,978
M01 · FY2001 · RR
MULTI COUNTRY RANDOMIZED, DOUBLE BLIND TRIAL ON EFFECT OF VALSARTAN IN CHF$982
M01 · FY2000 · RR
HEART &ESTROGEN REPLACEMENT STUDY (HERS)$982
M01 · FY2000 · RR
MULTI COUNTRY RANDOMIZED, DOUBLE BLIND TRIAL ON EFFECT OF VALSARTAN IN CHF$0
M01 · FY2000 · RR
MULTI COUNTRY RANDOMIZED, DOUBLE BLIND TRIAL ON EFFECT OF VALSARTAN IN CHF$0
M01 · FY2000 · RR